tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Jiangsu Hengrui Pharmaceuticals Proposes Amendments to Articles of Association
PremiumCompany AnnouncementsJiangsu Hengrui Pharmaceuticals Proposes Amendments to Articles of Association
3M ago
Jiangsu Hengrui Pharmaceuticals’ Drugs Added to National Reimbursement List
Premium
Company Announcements
Jiangsu Hengrui Pharmaceuticals’ Drugs Added to National Reimbursement List
3M ago
Jiangsu Hengrui Pharmaceuticals Appoints New Senior Vice President
Premium
Company Announcements
Jiangsu Hengrui Pharmaceuticals Appoints New Senior Vice President
3M ago
Jiangsu Hengrui Pharmaceuticals Approves Resolutions at 2025 Shareholders’ Meeting
PremiumCompany AnnouncementsJiangsu Hengrui Pharmaceuticals Approves Resolutions at 2025 Shareholders’ Meeting
5M ago
Positive Buy Rating for Jiangsu Hengrui Pharmaceuticals Driven by Strategic Out-Licensing and Promising HRS-1893 Data
Premium
Ratings
Positive Buy Rating for Jiangsu Hengrui Pharmaceuticals Driven by Strategic Out-Licensing and Promising HRS-1893 Data
6M ago
Jiangsu Hengrui Pharmaceuticals Licenses Innovative Drug to Braveheart Bio
Premium
Company Announcements
Jiangsu Hengrui Pharmaceuticals Licenses Innovative Drug to Braveheart Bio
6M ago
Jiangsu Hengrui Pharmaceuticals Reports Strong Interim Results for 2025
PremiumCompany AnnouncementsJiangsu Hengrui Pharmaceuticals Reports Strong Interim Results for 2025
6M ago
Jiangsu Hengrui Pharmaceuticals Approves 2025 Employee Stock Ownership Scheme
Premium
Company Announcements
Jiangsu Hengrui Pharmaceuticals Approves 2025 Employee Stock Ownership Scheme
6M ago
Jiangsu Hengrui Pharmaceuticals Announces Upcoming Board Meeting for Interim Results
Premium
Company Announcements
Jiangsu Hengrui Pharmaceuticals Announces Upcoming Board Meeting for Interim Results
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100